维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Navari R M"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Pathogenesis- based treatment o{ chemothera-py- induced nausea and vomiting two new agents 显示文摘	Navari R M	2003	J Support Oncol2003，1，：	1
2	Treatment of de- pressive symptoms in patients with early stage breast Cancer un- dergoing adjuvant therapy显示文摘	NAVARI R M BRENNER M C WII_SON M N	2008	Breast Cancer Research and Treat- merit2008，112，1：	1
3	Forsaprepitant:A neurokin-1 receptor an- tagonist for the prevention of chemotherapy - induced nausea and vomiting 显示文摘	NAVARI R M	2008	Expert Rev Anticancer Ther2008，8，11：	1
4	Management of chemotherapy-induced nausea and vomiting:focus on newer agents and new uses for older agents显示文摘	NAVARI R M	2013	Drugs2013，73，3：	1
5	Role of neurokinin-1 receptor antagonists in cheroot herapy-induced emesis summary of clinical trials 显示文摘	Navari R M	2004	Cancer Invest2004，22，4：	1
6	Management of chemotherapy-induced nausea andvomiting : focus on newer agents and new uses for older agents显示文摘	Navari R M	2013	Drugs2013，73，3：	1
7	Olanzapine for the prevention and treatment of chronic nausea and chemotherapy-induced naused and vomiting显示文摘	Navari R M	2014	European Journal of Pharmacology2014，722，：	1
8	The use of olanzapine versus metoclopramide for the treatment of breakthrough chemotherapy- induced nausea and vomiting in patients receiving highly emetogenic chemotharapy显示文摘	Navari R M Nagy C K Gray S E	2013	Supportive Care in Cancer2013，21，6：	1
9	A phase I trialof olanzapine for the prevention of delayed emesis in canc-er patients: a Hoosier Oncology Group Study 显示文摘	Passik S D Navari R M Jung S H	2004	CancerInvest2004，22，3：	1
10	Palonosetron:a second-generation 5-hydroxytryptamine receptor antagonist显示文摘	Navari R M	2006	2(5):591-6022006，2，5：	1
11	Preven-tionof cisplatin-induced acute and delayed emesis by theselective neurokinin-1 antagonists, L-758, 298 and MK-869显示文摘	Van Belle S Lichinitser M R Navari R M	2002	Cancer2002，94，11：	1
12	New approaches to chemotherapy-induced nausea and vomiting: from neuropharmacology to clinical investigations显示文摘	Rubenstein E B Slusher B S Rojas C Navari R M	2006	Cancer J2006，12，：	1
13	Palonosetmn: a second generation 5-hydmxytryptamine 3 receptor antagonist 显示文摘	NAVARI R M	2009	Expert Opin Drug Metab Toxieol2009，5，12：	1
14	Pathogenesis based treatment of chemotherapy induced nausea and vomiting two new agents显示文摘	Navari R M	2003	J Support Oncol2003，1，2：	1
15	Treatment of cancer-related anorexia with olanzapine and megestrol acetate : arandomized trial 显示文摘	NAVARI R M BRENNER M C	2010	Support Care Cancer2010，18，8：	1
16	Management of chemotherapy-induced nau- sea and vomiting: focus on newer agents and new uses for older agents显示文摘	Navari R M	2013	Drugs2013，73，3：	1
17	Growth and mineral absorption in maixe seedling as affected by increasing NaCl concentrations 显示文摘	Izzo R Navari Izzo F Quartacci M F	1991	J Plants Nutr1991，，14：	1
18	Role of neurokinin 1 receptor antagonists in chemotherapy-induced emesis:summary of clinical trials显示文摘	Navari R M	2004	Cancer Invest2004，22，4：	1
19	Pathogenesis-based treatment of chemotherapy-induced nausea vomiting-two new agents显示文摘	Navari R M	2003	J Support Oncol2003，1，2：	1
20	Aprepitant: a novel antiemetic for chemotherapy- induced nausea andvomiting显示文摘	Navari R M	2004	Expert Rev Anticancer Ther2004，4，5：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示